The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Improvement of Dyspnea and Palpitations of Cardiac Origin Using Comprehensive Traditional Korean Medicine Treatment Including Bangibokryeong-tang (Fangji Fuling Decoction) : A Case Report

심장성 원인의 호흡곤란 및 두근거림을 방기복령탕가미방(Fangji Fuling Decoction)을 포함한 복합 한의치료로 호전시킨 증례 1례 - 증례보고

  • Jumin Kim (College of Korean Medicine, Wonkwang University) ;
  • Dasol Park (College of Korean Medicine, Wonkwang University) ;
  • Hyeryun Lee (Cham Kyung-hee Korean Medicine Clinic) ;
  • Jungtae Leem (Dept. of Diagnostics, School of Korean Medicine, Wonkwang University)
  • 김주민 (원광대학교 한의과대학) ;
  • 박다솔 (원광대학교 한의과대학) ;
  • 이혜련 (참경희 한의원) ;
  • 임정태 (원광대학교 한의과대학 진단학교실)
  • Received : 2024.03.06
  • Accepted : 2024.04.06
  • Published : 2024.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

This case report demonstrates the effect of modified Bangibokryeong-tang (Fangji Fuling Decoction), a traditional herbal prescription in treating dyspnea and palpitations, symptoms that often lead to anxiety and reduced quality of life of cardiac patients. A female patient in her late 70s with congenital valve malformation and atrial fibrillation presented with dyspnea and palpitations, each rated at a severity of 8 on a numeric rating scale (NRS). After voluntarily discontinuing Western medication, she received modified BGBRT for 25 days, leading to significant symptom relief and NRS improvement to 0-2. The patient reported maintaining an improved condition and showed a significant increase in vitality. This improvement was sustained for 7 months, but the symptoms recurred; thus, modified BGBRT was restarted. Modified BGBRT showed substantial effects on persistent cardiac-origin dyspnea and palpitations. Thus, this TKM has the potential to manage symptoms and enhance the quality of life of cardiac patients.

Keywords

Acknowledgement

This work was supported by a National Research Foundation of Korea grant funded by the Korea government (No NRF-2022R1C1C2008738). This research was also supported by a grant of the Korea Health Technology Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HF23C0063)

References

  1. Joung B. Guideline of atrial fibrillation management. Journal of the Korean Medical Association 2019;62(5):265-74.  https://doi.org/10.5124/jkma.2019.62.5.265
  2. Oh SI. Pharmacological Treatment of Atrial Fibrillation. The Korean Journal of Medicine 2011;81(4):423-7. 
  3. Kim JC, Oh SW, Song CH, Lee SH, Jeong JJ, Sun SH. Case Report of Chengsim Yeunja-Tang (CYT) for Atrial Fibrillation with Cerebral-infarction. The Journal of Korean Oriental Internal Medicine 2006;27(3):751-61. 
  4. Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation 2021;144(24):1899-911. doi:10.1161/CIRCULATIONAHA.121.056456 
  5. Joung BY, Lee JM, Lee KH, Kim TH, Choi EK, Lim WH, et al. 2018 Korean Guideline of Atrial Fibrillation Management. Korean Circ J 2018;48(12):1033-80. doi:10.4070/kcj.2018.0339 
  6. Lim WH, Shim JM, Lee JH, Joung BY. 2021 Korean Heart Rhythm Society Guidelines for Catheter or Surgical Ablation of Atrial Fibrillation. The Korean Journal of Medicine 2022;97(1):5-22. doi:10.3904/kjm.2022.97.1.5 
  7. Lee YU, Kim KH, Kang GH, Kang SY, Song JH, Ji SH, et al. A Case Report of Complete Atrioventricular Block Treatment with Samulanshin-tang-gamibang and Acupuncture. The Journal of Korean Oriental Internal Medicine 2022;43(2):274-82. doi:10.22246/jikm.2022.43.2.274 
  8. Shin HR, Kim CH, Chu HM, Lee YU, Kim KH, Won JH, et al. A Case Report of a Mitral Stenosis Patient Treated with Korean Medicine. The Journal of Korean Oriental Internal Medicine 2020;41(3):457-66. doi:10.22246/jikm.2020.41.3.457 
  9. Zhang J, Quartz C, Guo H. Thoughts on the case study of Mu Fangji Decoction in treating palpitations. Accessed February 5, 2024. https://oversea-cnki-net.libproxy.wku.ac.kr/KCMS/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2021&filename=HQZY202106046&uniplatform=OVERSEA&v=RQjMH-XBjAypPJk_JYaSy1yRmDLcbcS7-cdSg-EH-4kxjIJ_vm-vhY9vML7TkLSH 
  10. Yuhuan L, Hong Y. Luo Yuhuan's Clinical Experience in Treating Refractory Arrhythmias. Global Chinese Medicine 2023;35(10):1944-7. DOI:10.16448/j.cjtcm.2023.1021. 
  11. Sarkar S, Amelung PJ. Evaluation of the Dyspneic Patient in the Office. Primary Care: Clinics in Office Practice 2006;33(3):643-57. doi:10.1016/j.pop.2006.06.007. 
  12. Budhwar N, Syed Z. Chronic Dyspnea: Diagnosis and Evaluation. afp 2020;101(9):542-8. 
  13. Abbott AV. Diagnostic approach to palpitations. Am Fam Physician 2005;71(4):743-50. 
  14. Kang YH. The Relationships among Uncertainty, Appraisal of Uncertainty, Depression, Anxiety and Perceived Health Status in Patients with Atrial Fibrillation. Korean Journal of Adult Nursing 2005;17(2):230-8. 
  15. Lee SJ, Seo JM. Factors Influencing Health-related Quality of Life in Patients with Atrial Fibrillation. Korean Journal of Adult Nursing 2013;25(1):13-23.  https://doi.org/10.7475/kjan.2013.25.1.13
  16. Fei Y, Fei R, Zhang J, Sun Y, Yu Q. Systematic Evaluation of Efficacy and Safety of Acupuncture Treatment for Patients with Atrial Fibrillation. Open Access Maced J Med Sci 2019;7(3):461-6. doi:10.3889/oamjms.2019.036 
  17. Lei Y, Tang Y, Huang L, He P. Systematic review and meta-analysis on efficacy of traditional Chinese medicine for atrial fibrillation through cluster analysis. Ann Palliat Med 2021;10(8):8982-90. doi:10.21037/apm-21-1785 
  18. Cai X, Wang Y, Li Z, Zhang Y, Wang D, Yan X. Chinese herbal medicine for patients with atrial fibrillation: protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2017;96(50):e9228. doi:10.1097/MD.0000000000009228 
  19. Lee SMK, Leem JT, Park JH, Yoon KH, Woo JS, Lee JM, et al. Close look at the experiences of patients enrolled in a clinical trial of acupuncture treatment for atrial fibrillation in Korea: a qualitative study nested within a randomised controlled trial. BMJ Open 2017;7(2):e013180. doi:10.1136/bmjopen-2016-013180 
  20. Ro SJ, Park KS, Kwon MJ, Yi YS, Jeong HY. Study On the "Diagnosis and Trearment of Edema" in the Chapter 14 of Synopsis of Golden Chamber. Journal of Physiology & Pathology in Korean Medicine 2008;22(1):60-81. 
  21. Wang H, Chen L, Wang S, Tian X, Zhang L, Li H, Li C, et al. Tetrandrine promotes angiogenesis via transcriptional regulation of VEGF-A. Vascular Pharmacology 2021;141:106920. doi:10.1016/j.vph.2021.106920 
  22. Zhang X, Gao Y, Zhou Y, Liu Z, Liu R. Pharmacological mechanism of natural drugs and their active ingredients in the treatment of arrhythmia via calcium channel regulation. Biomed Pharmacother 2023;160:114413. doi:10.1016/j.biopha.2023.114413 
  23. Ren J, Fu L, Nile SH, Zhang J, Kai G. Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications. Frontiers in Pharmacology 2019:10.Accessed February 19, 2024. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00753 
  24. Tsai MY, Hu WL, Lin CC, Lee YC, Chen SY, Hung YC, et al. Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study. International Journal of Cardiology 2017;228:90-6. doi:10.1016/j.ijcard.2016.11.172